Matches in SemOpenAlex for { <https://semopenalex.org/work/W2777886565> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W2777886565 endingPage "1401" @default.
- W2777886565 startingPage "1395" @default.
- W2777886565 abstract "Abstract Background & Aims Limited data have shown high efficacy of co‐formulated ombitasvir/paritaprevir/ritonavir ( OBV / PTV /r) in the treatment of hepatitis C virus ( HCV ) genotype ( GT )‐4, and combined with dasabuvir ( DSV ) in GT 1 patients, with chronic kidney disease ( CKD ) stages 4‐5 (<30 mL/min/1.73 m 2 ). We assessed real‐world safety and efficacy of OBV / PTV /r ± DSV in GT 1‐ and 4‐infected patients. Methods In this observational cohort (n = 67), we enrolled stages 4‐5 CKD treatment‐naïve or Peginterferon/ RBV ‐experienced GT 4‐infected patients (n = 32) treated for 12‐24 weeks with OBV / PTV /r ± RBV , and plus DSV in GT 1 patients (n = 35, including 3 with GT 1/4 co‐infection). RBV was dosed by physician discretion between 200 mg weekly and 200 mg daily. Primary endpoints were SVR 12, calculated on intention‐to‐treat ( ITT ) basis, and occurrence of serious adverse events. Results The mean age of the cohort was 45.7 ± 12.7 years, 50.7% were females, 20.9% had cirrhosis, 35.8% were treatment‐experienced and 97% were on haemodialysis. Three patients (F4) received 24‐week treatment, 2 with GT 4, and 1 with GT 1a; and 19.4% were treated without RBV , including 9 GT 1, and 4 GT 4. Overall, 65 (97.1%) patients achieved SVR 12, including 100% of those with a post‐treatment follow‐up (modified ITT analysis). Of the two patients without SVR 12, one died from sepsis‐related complications and the other from a myocardial infarction 2 weeks after completing therapy. Grades 3‐4 anaemia occurred in 8.9%. Conclusion A 12‐week regimen of OBV / PTV /r ± DSV with or without RBV is highly effective with a favourable safety profile amongst GT 4 and GT 1 patients with CKD stages 4‐5. SVR 12 rates were high regardless of patient characteristics." @default.
- W2777886565 created "2018-01-05" @default.
- W2777886565 creator A5002452894 @default.
- W2777886565 creator A5014120455 @default.
- W2777886565 creator A5048877999 @default.
- W2777886565 creator A5058815535 @default.
- W2777886565 creator A5068362077 @default.
- W2777886565 creator A5069112778 @default.
- W2777886565 creator A5069895457 @default.
- W2777886565 creator A5070129085 @default.
- W2777886565 creator A5072952036 @default.
- W2777886565 creator A5090751447 @default.
- W2777886565 date "2018-03-31" @default.
- W2777886565 modified "2023-10-06" @default.
- W2777886565 title "High Efficacy of ombitasvir/paritaprevir/ritonavir plus dasabuvir in hepatitis C genotypes 4 and 1-infected patients with severe chronic kidney disease" @default.
- W2777886565 cites W1908153784 @default.
- W2777886565 cites W1977300462 @default.
- W2777886565 cites W2019766614 @default.
- W2777886565 cites W2061364273 @default.
- W2777886565 cites W2063454558 @default.
- W2777886565 cites W2069465518 @default.
- W2777886565 cites W2113428683 @default.
- W2777886565 cites W2132581252 @default.
- W2777886565 cites W2296452901 @default.
- W2777886565 cites W2510132533 @default.
- W2777886565 cites W2567208426 @default.
- W2777886565 cites W2578013986 @default.
- W2777886565 cites W2761085897 @default.
- W2777886565 doi "https://doi.org/10.1111/liv.13674" @default.
- W2777886565 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29288514" @default.
- W2777886565 hasPublicationYear "2018" @default.
- W2777886565 type Work @default.
- W2777886565 sameAs 2777886565 @default.
- W2777886565 citedByCount "13" @default.
- W2777886565 countsByYear W27778865652018 @default.
- W2777886565 countsByYear W27778865652019 @default.
- W2777886565 countsByYear W27778865652020 @default.
- W2777886565 countsByYear W27778865652021 @default.
- W2777886565 countsByYear W27778865652023 @default.
- W2777886565 crossrefType "journal-article" @default.
- W2777886565 hasAuthorship W2777886565A5002452894 @default.
- W2777886565 hasAuthorship W2777886565A5014120455 @default.
- W2777886565 hasAuthorship W2777886565A5048877999 @default.
- W2777886565 hasAuthorship W2777886565A5058815535 @default.
- W2777886565 hasAuthorship W2777886565A5068362077 @default.
- W2777886565 hasAuthorship W2777886565A5069112778 @default.
- W2777886565 hasAuthorship W2777886565A5069895457 @default.
- W2777886565 hasAuthorship W2777886565A5070129085 @default.
- W2777886565 hasAuthorship W2777886565A5072952036 @default.
- W2777886565 hasAuthorship W2777886565A5090751447 @default.
- W2777886565 hasConcept C126322002 @default.
- W2777886565 hasConcept C142462285 @default.
- W2777886565 hasConcept C203014093 @default.
- W2777886565 hasConcept C2522874641 @default.
- W2777886565 hasConcept C2776408679 @default.
- W2777886565 hasConcept C2777100407 @default.
- W2777886565 hasConcept C2778653478 @default.
- W2777886565 hasConcept C2778785139 @default.
- W2777886565 hasConcept C2778867932 @default.
- W2777886565 hasConcept C2779298103 @default.
- W2777886565 hasConcept C2780040827 @default.
- W2777886565 hasConcept C2993143319 @default.
- W2777886565 hasConcept C71924100 @default.
- W2777886565 hasConcept C90924648 @default.
- W2777886565 hasConceptScore W2777886565C126322002 @default.
- W2777886565 hasConceptScore W2777886565C142462285 @default.
- W2777886565 hasConceptScore W2777886565C203014093 @default.
- W2777886565 hasConceptScore W2777886565C2522874641 @default.
- W2777886565 hasConceptScore W2777886565C2776408679 @default.
- W2777886565 hasConceptScore W2777886565C2777100407 @default.
- W2777886565 hasConceptScore W2777886565C2778653478 @default.
- W2777886565 hasConceptScore W2777886565C2778785139 @default.
- W2777886565 hasConceptScore W2777886565C2778867932 @default.
- W2777886565 hasConceptScore W2777886565C2779298103 @default.
- W2777886565 hasConceptScore W2777886565C2780040827 @default.
- W2777886565 hasConceptScore W2777886565C2993143319 @default.
- W2777886565 hasConceptScore W2777886565C71924100 @default.
- W2777886565 hasConceptScore W2777886565C90924648 @default.
- W2777886565 hasIssue "8" @default.
- W2777886565 hasLocation W27778865651 @default.
- W2777886565 hasOpenAccess W2777886565 @default.
- W2777886565 hasPrimaryLocation W27778865651 @default.
- W2777886565 hasRelatedWork W1746912726 @default.
- W2777886565 hasRelatedWork W2110220149 @default.
- W2777886565 hasRelatedWork W2197382142 @default.
- W2777886565 hasRelatedWork W2232566874 @default.
- W2777886565 hasRelatedWork W2399748013 @default.
- W2777886565 hasRelatedWork W2566205533 @default.
- W2777886565 hasRelatedWork W2753691577 @default.
- W2777886565 hasRelatedWork W2907309313 @default.
- W2777886565 hasRelatedWork W2946619231 @default.
- W2777886565 hasRelatedWork W3194055039 @default.
- W2777886565 hasVolume "38" @default.
- W2777886565 isParatext "false" @default.
- W2777886565 isRetracted "false" @default.
- W2777886565 magId "2777886565" @default.
- W2777886565 workType "article" @default.